Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-asparaginase during two treatment courses in childhood acute lymphoblastic leukemia
2005-000658-56Phase 4Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Dec 2005
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by Aarhus University Hospital. Primary endpoint: Frequency and level of anti-PEG-asparaginase antibodies. Started Dec 2005; status: terminated.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2005-000658-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000658-56.